This particular assay, referred to as PUBCHEM_BIOASSAY, is a high throughput dose response assay that relies on TR-FRET (time-resolved fluorescence resonance energy transfer) and biochemical methods to identify agonists of NR2E3, a member of the nuclear receptor subfamily 2, group E. This assay is classified as a confirmatory type, meaning that it is intended to confirm and validate previous results. In addition, there are two related PUBCHEM assays, namely 2379 (Screening (NR2E3 agonists, 3X)) and 2300 (Screening (NR2E3 agonists, 1X)), as well as 2325 (Summary), which serves as a summarization of the results obtained from the other two assays. Furthermore, this assay is assigned to a single protein target, which is why it is referred to as a direct single protein target assigned. Additional properties of the assay include the assay category, which is confirmatory; the assay organism, which is Homo sapiens; and the assay type description, which is functional. In relation to the present assay, can it be concluded that the molecule being used is efficient and producing the desired outcome?